🚀 RECENT AI SUCCESS

Our AI successfully predicted the gap for $SFIX and executed a BUY strategy, securing a +31.52% net profit.

UPGRADE TO SEE LIVE SIGNALS

$FATE

Fate Therapeutics Inc

United StatesUNITED STATES
FREE PREVIEW
📅 Next Earnings: Aug 11, 2026 ☀️ Open🌐 Website🏛️ NASDAQ📁 Health Technology🏭 Biotechnology
AVG HISTORICAL GAP0.83%
MAX GAP RECORD8.78%
PREMIUM
AI ACCURACY RATE
92.4%
Unlock AI Insights 🔓

LAST 10 EARNINGS GAPS (%)

VOLATILITY & BIAS PROFILE

AVG VOLATILITY3.0%
Bullish Gaps
Bearish Gaps
Neutral

Intelligence Brief

Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of products includes immuno-ocology candidates and immuno-regulation candidates. The company was founded by Philip Beachy, Sheng Ding, Rudolf Jaenisch, Randall T. Moon, Michael Rudnicki, David Scadden, Leonard Zon, Alexander Rives, Scott Wolchko, and John D. Mendlein on April 27, 2007 and is… Read full dossier

CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL